Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
Abstract Background Since the discovery of the induced pluripotent stem cell (iPSC) technique more than a decade ago, extensive progress has been made to develop clinically relevant cell culture systems. Alzheimer’s disease (AD) is the most common neurodegenerative disease, accounting for approximat...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-07-01
|
| Series: | Translational Neurodegeneration |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s40035-019-0161-0 |
| _version_ | 1811220345876643840 |
|---|---|
| author | Sherida de Leeuw Christian Tackenberg |
| author_facet | Sherida de Leeuw Christian Tackenberg |
| author_sort | Sherida de Leeuw |
| collection | DOAJ |
| description | Abstract Background Since the discovery of the induced pluripotent stem cell (iPSC) technique more than a decade ago, extensive progress has been made to develop clinically relevant cell culture systems. Alzheimer’s disease (AD) is the most common neurodegenerative disease, accounting for approximately two thirds of all cases of dementia. The massively increasing number of affected individuals explains the major interest of research in this disease as well as the strong need for better understanding of disease mechanisms. Main body IPSC-derived neural cells have been widely used to recapitulating key aspects of AD. In this Review we highlight the progress made in studying AD pathophysiology and address the currently available techniques, such as specific differentiation techniques for AD-relevant cell types as well as 2D and 3D cultures. Finally, we critically discuss the key challenges and future directions of this field and how some of the major limitations of the iPSC technique may be overcome. Conclusion Stem cell-based disease models have the potential to induce a paradigm shift in biomedical research. In particular, the combination of the iPSC technology with recent advances in gene editing or 3D cell cultures represents a breakthrough for in vitro disease modeling and provides a platform for a better understanding of disease mechanisms in human cells and the discovery of novel therapeutics. |
| first_indexed | 2024-04-12T07:40:26Z |
| format | Article |
| id | doaj.art-a2df2a8aa8de47c793783fc35fcc81c8 |
| institution | Directory Open Access Journal |
| issn | 2047-9158 |
| language | English |
| last_indexed | 2024-04-12T07:40:26Z |
| publishDate | 2019-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Translational Neurodegeneration |
| spelling | doaj.art-a2df2a8aa8de47c793783fc35fcc81c82022-12-22T03:41:50ZengBMCTranslational Neurodegeneration2047-91582019-07-018111310.1186/s40035-019-0161-0Alzheimer’s in a dish – induced pluripotent stem cell-based disease modelingSherida de Leeuw0Christian Tackenberg1Institute for Regenerative Medicine, University of ZurichInstitute for Regenerative Medicine, University of ZurichAbstract Background Since the discovery of the induced pluripotent stem cell (iPSC) technique more than a decade ago, extensive progress has been made to develop clinically relevant cell culture systems. Alzheimer’s disease (AD) is the most common neurodegenerative disease, accounting for approximately two thirds of all cases of dementia. The massively increasing number of affected individuals explains the major interest of research in this disease as well as the strong need for better understanding of disease mechanisms. Main body IPSC-derived neural cells have been widely used to recapitulating key aspects of AD. In this Review we highlight the progress made in studying AD pathophysiology and address the currently available techniques, such as specific differentiation techniques for AD-relevant cell types as well as 2D and 3D cultures. Finally, we critically discuss the key challenges and future directions of this field and how some of the major limitations of the iPSC technique may be overcome. Conclusion Stem cell-based disease models have the potential to induce a paradigm shift in biomedical research. In particular, the combination of the iPSC technology with recent advances in gene editing or 3D cell cultures represents a breakthrough for in vitro disease modeling and provides a platform for a better understanding of disease mechanisms in human cells and the discovery of novel therapeutics.http://link.springer.com/article/10.1186/s40035-019-0161-0Alzheimer’s diseaseInduced pluripotent stem cellsiPSC-derived neuronsiPSC-derived astrocytesiPSC-derived microgliaDisease modeling |
| spellingShingle | Sherida de Leeuw Christian Tackenberg Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling Translational Neurodegeneration Alzheimer’s disease Induced pluripotent stem cells iPSC-derived neurons iPSC-derived astrocytes iPSC-derived microglia Disease modeling |
| title | Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling |
| title_full | Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling |
| title_fullStr | Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling |
| title_full_unstemmed | Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling |
| title_short | Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling |
| title_sort | alzheimer s in a dish induced pluripotent stem cell based disease modeling |
| topic | Alzheimer’s disease Induced pluripotent stem cells iPSC-derived neurons iPSC-derived astrocytes iPSC-derived microglia Disease modeling |
| url | http://link.springer.com/article/10.1186/s40035-019-0161-0 |
| work_keys_str_mv | AT sheridadeleeuw alzheimersinadishinducedpluripotentstemcellbaseddiseasemodeling AT christiantackenberg alzheimersinadishinducedpluripotentstemcellbaseddiseasemodeling |